Free Account Opening + AMC Free Demat
Loading...

Alkali Metals IPO vs Chemcel Biotech IPO

Comparision between Alkali Metals IPO and Chemcel Biotech IPO.

IPO Details

Alkali Metals IPO is a Mainline Fixed Price Issue IPO proposed to list at BSE, NSE while Chemcel Biotech IPO is a Mainline Fixed Price Issue proposed to list at BSE.

  Alkali Metals IPO Chemcel Biotech IPO
Logo Alkali Metals IPO Logo Chemcel Biotech IPO Logo
Issue Category Mainline Mainline
Issue Type IPO IPO
Process Type Book Built Issue Fixed Price Issue
Listing At BSE, NSE BSE
Lead Managers Saffron Capital Advisors Private Limited Allahabad Bank
Registrar Cameo Corporate Services Limited Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Alkali Metals IPO is up to ₹26.27 Cr whereas the issue size of the Chemcel Biotech IPO is up to ₹24.64 Cr. The final issue price of Alkali Metals IPO is ₹103.00 per share and of Chemcel Biotech IPO is ₹16.00 per share.

  Alkali Metals IPO Chemcel Biotech IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹86.00 per share
Issue Price (Upper) ₹103.00 per share
Issue Price (Final) ₹103.00 per share ₹16.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 65 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 25,50,000 shares 1,54,00,000 shares
Issue Size Total (Amount) up to ₹26.27 Cr up to ₹24.64 Cr

IPO Timetable

Alkali Metals IPO opens on Oct 07, 2008, while Chemcel Biotech IPO opens on Sep 09, 2008. The closing date of Alkali Metals IPO and Chemcel Biotech IPO is Oct 15, 2008, and Sep 12, 2008, respectively.

  Alkali Metals IPO Chemcel Biotech IPO
Anchor Bid Date
Issue Open Oct 07, 2008 Sep 09, 2008
Issue Close Oct 15, 2008 Sep 12, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Alkali Metals IPO P/E ratio is , as compared to Chemcel Biotech IPO P/E ratio of .

  Alkali Metals IPO Chemcel Biotech IPO
Financial
ParticularsFor the year/period ended (Rs. in Millions)
  31-Mar-0831-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income653.35640.00649.36406.89426.45
  Profit After Tax (PAT)79.3276.05132.9947.0563.34
ParticularsFor the year/period ended (Rs. in Lacs)
  30-Jun-0731-Mar-0731-Mar-0631-Mar-0531-Mar-04
  Total Income61.172347.662180.081223.811337.96
  Profit After Tax (PAT)10.3793.6275.6818.398.41
Promoter Shareholding (Pre-Issue) 99.99% 57.23%
Promoter Shareholding (Post-Issue) 74.95% 29.4%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 23.27%% 9.14%%

Shares Offered

In the Alkali Metals IPO retail investors (RII) are offered while in Chemcel Biotech IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Alkali Metals IPO and in Chemcel Biotech IPO.

  Alkali Metals IPO Chemcel Biotech IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Alkali Metals IPO subscribed 1.04x in total, whereas Chemcel Biotech IPO subscribed .

  Alkali Metals IPO Chemcel Biotech IPO
QIB (times) 0.72x
NII (times) 3.09x
Big NII (times)
Small NII (times)
RII (times) 0.63x
Employee (times)
Other (times)
Total (times) 1.04x

Comments

Add a public comment...